Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options

Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options have?

Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options has 31 citations in the OpenAlex counts ScholarIQ stores.

When was Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options published?

Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options has 2022 year in the ScholarIQ index.

What is the open-access status of Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options?

Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options has diamond oa status in the ScholarIQ index.

What is the DOI of Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options?

The DOI for Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options is on the source record.

What is the PMID of Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options?

The PMID for Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options is on the source record.

What is the OpenAlex record for Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options?

The OpenAlex for Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options is on the source record.